Rpg Life Sciences

Harsh Goenka-backed RPG Life Sciences surges 15% on solid Q1FY25 results

Shares of small cap firm RPG Life Sciences surged up to 14.81 per cent, hitting its 52-week high at Rs 2057.15 per share on the BSE in Monday's intraday deals

Buy Equitas Bank, RPG Life for up to 16% upside, recommends HDFC Securities

On the broader market outlook, Vinay Rajani the technical & derivative analyst says that the Nifty needs to breakout from the 18,669 - 18,888 range to gain momentum.

RPG Life Sciences net profit rises 14% at Rs 15 crore in third quarter

RPG Life Sciences said its net profit increased 14 per cent to Rs 14.63 crore for the third quarter ended December 31, 2021.

RPG Life Sciences hits record high, zooms 51% so far in September

The domestic formulations business of the company will continue to focus on building chronic therapies, expanding specialty portfolio and life cycle management of current legacy products

RPG Life Sciences delivers life-saving drugs directly to patients

Despite the pharmaceutical industry having the essential commodities tag, the administration, police and building societies was not allowing movement of people and products

RPG Life Sciences zooms 20% as PBT jumps four-fold in Q2

Meanwhile, operational revenue during the quarter grew 8.8 per cent at Rs 98.49 crore, as against Rs 90.5 crore in the corresponding quarter of the previous year.

RPG Life Sciences targets Rs 1,000-cr revenue in 5 yrs

Pharma company to enter US market in two-three years

RPG Life Sciences targets Rs 1,000 crore revenue in five years

The company is diversifying in new areas such as cosmetology and dermatology

RPG Life Sciences surges on forays into cosmetic industry; credit rating upgrade

The stock surged 17% to Rs 273 on the BSE on back of heavy volumes.

RPG Life Sciences sells biotech business to Intas Pharmaceuticals

The formulations business contributes about 60 per cent to company's overall sales